Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

2018 Pan Pacific Lymphoma Conference
N

Optimum Therapy for Standard Risk High Grade - DLBCL

By 2018 Pan Pacific Lymphoma Conference FEATURING Nancy L. Bartlett
By 2018 Pan Pacific Lymphoma Conference FEATURING Nancy L. Bartlett
280 views
August 15, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss
High Grade B-cell Lymphoma
19:22

Challenges of Treating HGBCL Patients with Comorbidities: Anthracycl…

2018 Pan Pacific Lymphoma Conference

L. Sehn

192 views
17:51

Optimum Therapy for Standard Risk High Grade - DLBCL

2018 Pan Pacific Lymphoma Conference

N. Bartlett

280 views
10:46

New Approaches to Initial treatment of DLBCL: R-CHOP +

2018 Pan Pacific Lymphoma Conference

N. Bartlett

551 views
15:30

Challenges of Treating HGBCL Patients with Comorbidities: Who is "FI…

2018 Pan Pacific Lymphoma Conference

L. Sehn

280 views
21:17

Burkitt Lymphoma- R-Epoch for All?

2018 Pan Pacific Lymphoma Conference

M. Roschewski

98 views
08:52

Concurrent Systemic and CNS Aggressive NHL: How to Manage?

2018 Pan Pacific Lymphoma Conference

P. Bierman

41 views
26:03

Therapy for Double/Triple Hit-HGBCL

2018 Pan Pacific Lymphoma Conference

S. Smith

218 views
25:59

There is a Role for Lymphoma HDT/ASCT in the New Era of CAR T-cells!

2018 Pan Pacific Lymphoma Conference

C. Moskowitz

209 views
16:20

Is there a role for upfront transplantation in CNS Aggressive NHL

2018 Pan Pacific Lymphoma Conference

P. Bierman

27 views